SLC5A3 and diffuse large B-cell lymphoma: IHC analysis of 58 DLBCL specimens stratified patients into SMIT1-high and SMIT1-low subgroups, revealing SMIT1 overexpression in advanced Ann Arbor stage III-IV tumors (Fig. 1H; Tab.